Navigation Links
Russian Government Starts Using Scopus for National Research Assessment
Date:1/22/2013

MOSCOW, January 22, 2013 /PRNewswire/ --

Scopus used as assessment tool within Russia's state program "Science and Technology Development 2013-2020"

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that the Russian government has officially selected Scopus as a tool for its national research assessment. Measuring research performance forms a significant part of Russia's "Science and Technology Development in 2013-2020" program as declared by Prime Minister Dmitry Medvedev in 2012.

The aim of Russia's "Science and Technology Development in 2013-2020" program is to create an internationally competitive and well-functioning R&D sector, one in which efforts to modernize the economy are supported by science, technology and innovation. Within the program there is an emphasis on research assessment, measuring not only quantity but also quality of research output. Using data from Scopus, the Russian government will be able to map out its national research landscape, and compare it with other countries.

Ivan Sterligov, Director of Center of Situational Analysis at Russia's Ministry of Education and Science, noted, "Our state program is aimed at creating an innovative, secure infrastructure for Russian science and increase the efficiency of our fundamental and applied research. It will allow us to allocate financial resources to priority areas in science and technology. As a widely recognized and trusted source of scientific data, Scopus will help us define effective criteria for this."

Igor Osipov , PhD, Elsevier Regional Director for Russia and Belarus said, "Elsevier is honored to further develop its collaboration with the Russian government. Scopus will provide baseline data to assess research output across Russia in a strategic, forward-looking manner. We consider the launch of the program by Prime Minister Dmitry Medvedev a landmark event in the reform of science and education and a significant step towards quality benchmarking data for Russian researchers and decision makers, both in Russia and in an international context."

About Scopus

Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature. Featuring smart tools to track, analyze and visualize research, Scopus was designed and developed with input from over 500 users and librarians internationally. Its unique database contains abstracts and references from nearly 20,500 peer-reviewed journals from more than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage. Direct links to subscribed full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool.  

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Galina Yakshonak
Elsevier, Russia
+7-985-72-779-67
g.yakshonak@elsevier.com



'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AtheroNova Announces Milestone Filing of IND in Russian Federation
2. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
3. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
4. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
5. Innovation Names Dr. Phil Samples Vice President, Government & Professional Services
6. Government Hospitals in Ecuador Continue to Invest in Integrity Life Sciences Technology
7. Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan
8. Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth
9. MedicareBlue Rx Drug Plan Earns Federal Governments Top Rating
10. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
11. Patient Monitoring Devices Market in Emerging Countries (China, India, Brazil) to 2017 - Increasing Government Spending and Foreign Direct Investment (FDI) to Drive Future Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... 28, 2016 Dr. Vivek Ahuja ... and Ste phen Schmidt ... leading provider of cloud-based software solutions for life sciences, today announced ... bring a wealth of insight to a growing business.  This will ... George Phillips joined ArisGlobal in the position of ...
Breaking Medicine Technology:
(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the ... of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott ...
Breaking Medicine News(10 mins):